[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT01822834":3,"trial-entities:NCT01822834":65,"trial-summary:NCT01822834":70},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":20,"study_type":21,"primary_purpose":14,"phases":22,"enrollment_info":23,"interventions":26,"primary_outcomes":27,"secondary_outcomes":32,"sex":33,"minimum_age":34,"maximum_age":35,"healthy_volunteers":36,"eligibility_criteria":37,"std_ages":45,"locations":48,"central_contacts":56,"overall_officials":62,"references":63,"see_also_links":64},"NCT01822834","BRR","Bronchiectasis and NTM Research Registry","RECRUITING","2050-12","2022-03","2022-03-22","2008-01","COPD Foundation","OTHER",null,"The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.","The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions. The goal of the Bronchiectasis Research Registry is to support collaborative research and assist in the planning of multi-center clinical trials for the treatment of NTM and non-CF Bronchiectasis, a progressive, non-curable disease of the lungs, which afflicts thousands of patients. The Registry will also be used to provide better insight into the study of the different types of Bronchiectasis, as well as the pathophysiology of the disorder. In 2012, in collaboration with NTM Info and Research, Inc (NTMir) and the consortium members, the COPD Foundation expanded the Bronchiectasis Research Registry to enroll patients with \"non tuberculous mycobacteria (NTM) only\". Prior to this time, the registry included individuals with Bronchiectasis, with or without NTM.",[18,19],"Non-CF Bronchiectasis","Nontuberculosis Mycobacteria (NTM)",[],"OBSERVATIONAL",[],{"count":24,"type":25},5000,"ESTIMATED",[],[28],{"measure":29,"description":30,"timeFrame":31},"Patient Recruitment and Data analysis","The COPD Foundation expects to assist at least 4 researchers (with patient recruitment and\u002For data analysis) annually.","December 2050",[],"ALL","18 Years","120 Years",true,{"inclusion":38,"exclusion":41,"raw_text":44},[39,40,19],"Over the age of 18","non-CF Bronchiectasis",[42,43],"Under the age of 18","CF Bronchiectasis","Inclusion Criteria:\n\n* Over the age of 18\n* non-CF Bronchiectasis\n* Nontuberculosis Mycobacteria (NTM)\n\nExclusion Criteria:\n\n* Under the age of 18\n* CF Bronchiectasis",[46,47],"ADULT","OLDER_ADULT",[49],{"facility":12,"status":7,"city":50,"state":51,"country":52,"geoPoint":53},"Washington D.C.","District of Columbia","United States",{"lat":54,"lon":55},38.89511,-77.03637,[57],{"name":58,"role":59,"phone":60,"phoneExt":61},"Delia Prieto","CONTACT","1-866-731-2673","272",[],[],[],{"nct_id":4,"conditions":66,"biomarkers":69},[67,68],"Bronchiectasis","Nontuberculosis Mycobacteria",[],{"nct_id":4,"found":36,"summary":71,"prompt_version":80},{"design":72,"status":73,"heading":6,"summary":74,"follow_up":75,"word_count":76,"commitments":77,"compensation":78,"drugs_mentioned":79},"This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to enroll up to 5000 participants.","completed","This is a research registry, which is a database of information, for people with non-cystic fibrosis (non-CF) Bronchiectasis and\u002For Nontuberculosis Mycobacteria (NTM). Bronchiectasis is a progressive lung disease. The goal is to gather information from many patients to help researchers better understand these conditions and plan future studies. This registry is open to adults aged 18 and older who have non-CF Bronchiectasis or NTM. The study aims to collect and analyze patient data until December 2050 to support collaborative research.","Patient data will be analyzed until December 2050.",80,"Not specified in the trial record.","Not stated in the trial record.",[],"v2"]